Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04671186 · ClinicalTrials.gov registry record · NA
Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT04671186 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 47 participants.
The verdict
NCT04671186, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the role of probiotics in the treatment of pediatric NAFLD by evaluating for steatosis and fibrosis with a Fibroscan machine. This will be done by performing a fibroscan during each visit and comparing patients' ALT at various intervals. This is an important study as current pediatric guidelines only recommend lifestyle modifications for the treatment of NAFLD and the use of ALT and sonogram to assess improvement as standard of care. Investigators hypothesized that treatment with a probiotic will demonstrate an improvement in NAFLD as assessed by a fibroscan of liver which is good for the monitoring of steatosis and fibrosis. Additionally, analysis of fecal microbiome results may offer insight into targeted therapy in the future.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Culturelle (Lactobacillus rhamnosus strain GG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-09-07 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04671186
The ClinicalTrials.gov registry entry for NCT04671186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04671186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04671186 about?
NCT04671186 is a clinical study titled "Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan". The goal of this study is to evaluate the role of probiotics in the treatment of pediatric NAFLD by evaluating for steatosis and fibrosis with a Fibroscan machine. This will be done by performing a fibroscan during each visit and comparing patients' ALT at various intervals. This is an important stu...
What is the current status of trial NCT04671186?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2020-09-07. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT04671186?
The interventions under investigation include: Placebo (OTHER), Culturelle (Lactobacillus rhamnosus strain GG) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04671186?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.